Actionable news
All posts from Actionable news
Actionable news in SRPT: Sarepta Therapeutics, Inc.,

Sarepta's CEO: Patient input matters

Sarepta interim CEO Ed Kaye reacts to FDA panel's negative decision on data supporting approval of Duchenne muscular dystrophy drug.

  • You May Like

  • Make It: Dreamers, Seekers and Game-Changers

  • ...